4.6 Article

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Related references

Note: Only part of the references are listed.
Letter Dermatology

Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+M2 Macrophages

Taku Fujimura et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Review Oncology

Targeting RANKL in breast cancer: bone metastasis and beyond

Hamdy Azim et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2013)

Article Multidisciplinary Sciences

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

Eva Gonzalez-Suarez et al.

NATURE (2010)

Article Immunology

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Loise M. Francisco et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Review Oncology

CCR4 as a novel molecular target for immunotherapy of cancer

Takashi Ishida et al.

CANCER SCIENCE (2006)